Transcription Factor TFIIA (TFIIA)
An RNA POLYMERASE II specific transcription factor. It may play a role in transcriptional activation of gene expression by interacting with the TATA-BOX BINDING PROTEIN component of TRANSCRIPTION FACTOR TFIID.
Also Known As:
TFIIA; RNA Polymerase II, Transcription Factor A
Networked: 13
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Awah, Chidiebere U:
1 article
(12/2021)
|
2. | Mazdoom, Claudiane M:
1 article
(12/2021)
|
3. | Ogunwobi, Olorunseun O:
1 article
(12/2021)
|
4. | Winter, Jan:
1 article
(12/2021)
|
5. | Cramer, Patrick:
1 article
(01/2021)
|
6. | Wang, Haibo:
1 article
(01/2021)
|
7. | Xiong, Le:
1 article
(01/2021)
|
8. | Dvorak, Pavel:
1 article
(01/2019)
|
9. | Leupen, Sarah:
1 article
(01/2019)
|
10. | Soucek, Pavel:
1 article
(01/2019)
|
Related Diseases
1. | Neoplasms (Cancer)
05/11/2001
- " The NH(2)-terminal kinase domain of TAF(II)250 was sufficient for TFIIA phosphorylation, and this activity was inhibited by full-length retinoblastoma protein but not by a retinoblastoma protein mutant defective for TAF(II)250 interaction or tumor suppressor activity. " 01/01/2019
- " Exon and intron enhancers and silencers (sc35, ighg2 cgamma2, ctnt, gh-1, and fibronectin eda exon), transcription factors (TFIIA, TATA, NFAT1, NFAT4, and HOXA13), some of them cancer related, and microRNA (hsa-miR-4474-3p) were localized to these regions. "
|
2. | Decompression Sickness (Bends)
|
3. | Carcinogenesis
|
4. | Tics (Tic)
|
5. | Embryonal Carcinoma
|
|
Related Drugs and Biologics